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• Structural changes: no statistically
significant differences were found for de
novo copy number variations among
hESCs, hiPSCs and NT-hESCs.
• Non-structural changes: more de novo
coding unique mutations were confirmed
in hiPSCs and NT-hESCs compared to
hESCs, although no statistically significant
differences were found among both
reprogrammed cell types.
DNA methylation patterns, involving
imprinted genes and X chromosomal loci,
and transcriptome showed very little
difference among hESCs and NT-hESCs.
Nevertheless, results were not conclusive for
hiPSCs: Johannesson et al. (2014) also found
very little difference between the three cell
types, whereas Ma et al. (2014) showed that
hiPSCs retained more epigenetic memory
and presented more random reprogramming
errors comparing to NT-hESCs.Figure 2. Comparison of genetic and epigenetic characteristics of various pluripotent stem cells.
Relative similarity of human iPSCs (hiPSCs) and NT-ESCs (NT-hESCs) compared to human ESCs (hESCs)
IMMUNOGENICITYFUNCTIONAL CHARACTERISTICS iPSCs / ESCs
NT-ESCs are mismatched mitochondria, which cause alloantigenicity and make an
immune rejection possible. Mouse NT-ESCs (NT-mESCs) with allogenic mitochondria
and nucleus-identical to the recipient mouse may trigger an immune response when
transplanted to the mouse, impairing the survival of NT-mESCs graft. The immune
response caused is adaptive, directed against mitochondrial content and amenable
for tolerance induction.
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CONCLUSIONS REFERENCES
NT-ESCs are more faithfully reprogrammed than iPSCs, although iPSCs from late
passages present less cell memory than early passages’ ones and are molecularly and
functionally indistinguishable.
Regarding to immunogenicity, the possibility of autologous iPSC-derived cell
transplant immune response is still a topic of debate. About NT-ESCs, mismatched
mitochondria cause immune adaptive response.
Further research will assess functionality –especially of NT-ESCs– and immunogenicity
of pluripotent cells.
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Stem cells are unspecialized cells that are capable of self-renewal and can develop many different cell types.
Embryonic stem cells (ESCs) are derived from early embryonic development of embryos fertilized in vitro. Other
pluripotent stem cells can be obtained by reprogramming methods:
• Induced pluripotent stem cells (iPSCs) are reprogrammed from somatic cells by forcing them to express four
transcription factors: Oct4, Sox2, Klf4 and c-Myc.
• Nuclear-transfer-derived embryonic stem cells (NT-ESCs) are reprogrammed inserting the nucleus of a somatic cell
into an enucleated oocyte.
Both iPSCs and NT-ESCs have similar properties to ESCs, but they are not identical.
The objective of this bibliographic review is to compare different characteristics of ESCs, iPSCs and NT-ESCs to find
similarities and differences among reprogrammed pluripotent cells and embryonic stem cells.
INTRODUCTION
Figure 3. iPSCs derived from different somatic cell types retain a transient cell
memory at early-passage, which affects to the differentiation potential of
iPSCs. However, continuous passaging leads to the loss of this memory.
Late-passage iPSCs are molecularly and functionally indistinguishable.
Genetic and epigenetic variations –such as aberrant epigenetic statuses on certain loci
or source cell memory– may have an impact on iPSCs differentiation potential,
inducing that cell type of origin may bias the differentiation potential into the cell
lineage of origin.
Nevertheless, cell memory can be erased by continued passaging, which leads to
molecularly and functionally indistinguishable iPSCs and indicates that
reprogramming process is gradual.
Table 1. Summary of mouse iPSCs (miPSCs) immunogenicity data reported in three studies. Finding
immune response of autologous iPSC-derived cell transplants was unexpected. Nevertheless, more
recent reports support the immune privilege of iPSC-derived cells and their safety.
Figure 1. Obtaining ESCs and reprogrammed cells by defined factors
(iPSCs) and nuclear transfer (NT-ESCs)
